Jeff Cohen | Executive Director, Assistant General Counsel and Assistant Secretary |
Craig Collard | Chief Executive Officer |
Ira Duarte | Executive Vice President and Chief Financial Officer |
Bill Forbes | Executive Vice President and Chief Development Officer |
Serge Belanger | Needham & Company |
Boris Peaker | TD Cowen |
Carl Byrnes | Northland Capital Markets |
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Second Quarter 2023 Earnings Conference Call.
As a reminder, this conference is being recorded.
Now, I would like to turn the call over to Jeff Cohen, Executive Director, Assistant General Counsel and Assistant Secretary. Please proceed.